Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
VMF
0
Australia
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate, Chloromethyl
2. Alrex
3. Cehoac
4. Chloromethyl 17 Ethoxycarbonyloxy 11 Hydroxy 3 Oxoandrosta 1,4 Diene 17 Carboxylate
5. Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-3-oxoandrosta-1,4-diene-17-carboxylate
6. Etabonate, Loteprednol
7. Lotemax
8. Loteprednol
1. 82034-46-6
2. Lotemax
3. Alrex
4. Hgp-1
5. Inveltys
6. Cddd-5604
7. P-5604
8. Cddd 5604
9. Chloromethyl (8s,9s,10r,11s,13s,14s,17r)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthrene-17-carboxylate
10. Chebi:31784
11. Yeh1ez96k6
12. Kpi-121
13. Dsstox_cid_26468
14. Dsstox_rid_81641
15. Dsstox_gsid_46468
16. (11b,17a)-17-[(ethoxycarbonyl)oxy]-11-hydroxy-3-oxo-androsta-1,4-diene-17-carboxylic Acid Chloromethyl Ester
17. Chloromethyl 17alpha-[(ethoxycarbonyl)oxy]-11beta-hydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate
18. Loterox
19. Locort
20. Lotemax (tn)
21. Cas-82034-46-6
22. Unii-yeh1ez96k6
23. Hgp 1
24. Loteprednol Etabonate [usan]
25. Airex
26. Loteprednol Etabonate (jan/usan)
27. Loteprednoletabonate
28. Ncgc00164594-01
29. Idr-90102
30. Idr-90103
31. Eysuvis
32. Loteprednol Etabonate Opphthalmic Suspension
33. P 5604
34. Schembl23907
35. Mls001424221
36. Gtpl7085
37. Chembl1200865
38. Dtxsid2046468
39. Hms2051f16
40. Hms2232j09
41. Hms3715n06
42. Loteprednol Etabonate [mi]
43. Loteprednol Etabonate [usan:jan]
44. Loteprednol Etabonate [jan]
45. Bcp28645
46. Zinc3920673
47. Tox21_112219
48. Bdbm50248301
49. Loteprednol Etabonate [vandf]
50. Mfcd00870765
51. S1669
52. Loteprednol Etabonate [mart.]
53. Akos005145741
54. Loteprednol Etabonate [who-dd]
55. Tox21_112219_1
56. Ccg-101041
57. Cs-0900
58. Db14596
59. Gs-3599
60. Nc00291
61. Loteprednol Etabonate, >=98% (hplc)
62. Ncgc00164594-02
63. Chloromethyl 11beta,17-dihydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate, 17-(ethyl Carbonate)
64. Hy-17358
65. Smr000469178
66. Loteprednol Etabonate [orange Book]
67. Zylet Component Loteprednol Etabonate
68. L0327
69. D01689
70. Loteprednol Etabonate Component Of Zylet
71. Ab00698349-05
72. Ab00698349-07
73. Ab00698349_08
74. 034l466
75. Q3837481
76. Androsta-1,4-diene-17-carboxylic Acid, 17-((ethoxycarbonyl)oxy)-11-hydroxy-3-oxo-, Chloromethyl Ester, (11.beta.,17.alpha.)-
77. Androsta-1,4-diene-17-carboxylic Acid, 17-((ethoxycarbonyl)oxy)-11-hydroxy-3-oxo-, Chloromethyl Ester, (11beta,17alpha)-
78. Chloromethyl (1s,2r,10s,11s,14r,15s,17s)-14-[(ethoxycarbonyl)oxy]-17-hydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-14-carboxylate
79. Chloromethyl 11.beta.,17-dihydroxy-3-oxoandrosta-1,4-diene-17.beta.-carboxylate, 17-(ethyl Carbonate)
| Molecular Weight | 466.9 g/mol |
|---|---|
| Molecular Formula | C24H31ClO7 |
| XLogP3 | 3.9 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | 466.1758310 g/mol |
| Monoisotopic Mass | 466.1758310 g/mol |
| Topological Polar Surface Area | 99.1 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 882 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 4 | |
|---|---|
| Drug Name | Alrex |
| Drug Label | ALREX (loteprednol etabonate ophthalmic suspension) contains a sterile, topical anti-inflammatory corticosteroid for ophthalmic use.Loteprednol etabonate is a white to off-white powder.Loteprednol etabonate is represented by the following structura... |
| Active Ingredient | Loteprednol etabonate |
| Dosage Form | Suspension/drops |
| Route | Ophthalmic |
| Strength | 0.2% |
| Market Status | Prescription |
| Company | Bausch And Lomb |
| 2 of 4 | |
|---|---|
| Drug Name | Lotemax |
| PubMed Health | Loteprednol (Into the eye) |
| Drug Classes | Ophthalmologic Agent |
| Drug Label | LOTEMAX (loteprednol etabonate ophthalmic suspension) contains a sterile, topical anti-inflammatory corticosteroid for ophthalmic use. Loteprednol etabonate is a white to off-white powder.Loteprednol etabonate is represented by the following struct... |
| Active Ingredient | Loteprednol etabonate |
| Dosage Form | Ointment; Gel; Suspension/drops |
| Route | Ophthalmic |
| Strength | 0.5% |
| Market Status | Prescription |
| Company | Bausch And Lomb |
| 3 of 4 | |
|---|---|
| Drug Name | Alrex |
| Drug Label | ALREX (loteprednol etabonate ophthalmic suspension) contains a sterile, topical anti-inflammatory corticosteroid for ophthalmic use.Loteprednol etabonate is a white to off-white powder.Loteprednol etabonate is represented by the following structura... |
| Active Ingredient | Loteprednol etabonate |
| Dosage Form | Suspension/drops |
| Route | Ophthalmic |
| Strength | 0.2% |
| Market Status | Prescription |
| Company | Bausch And Lomb |
| 4 of 4 | |
|---|---|
| Drug Name | Lotemax |
| PubMed Health | Loteprednol (Into the eye) |
| Drug Classes | Ophthalmologic Agent |
| Drug Label | LOTEMAX (loteprednol etabonate ophthalmic suspension) contains a sterile, topical anti-inflammatory corticosteroid for ophthalmic use. Loteprednol etabonate is a white to off-white powder.Loteprednol etabonate is represented by the following struct... |
| Active Ingredient | Loteprednol etabonate |
| Dosage Form | Ointment; Gel; Suspension/drops |
| Route | Ophthalmic |
| Strength | 0.5% |
| Market Status | Prescription |
| Company | Bausch And Lomb |
A number of prescription loteprednol etabonate ophthalmic products are specifically indicated for the treatment of post-operative inflammation and pain following ocular surgery.
FDA Label
Loteprednol etabonate (LE) belongs to a unique class of corticosteroids with potent anti-inflammatory effects designed to be active at the site of action. Animal studies have shown that LE has a binding affinity to steroid receptors that is 4.3 times greater than dexamethasone. This particular class of steroids consists of bioactive molecules whose in-vivo transformation to non-toxic substances can be predicted from their chemistry and knowledge of enzymatic pathways in the body. Cortienic acid is an inactive metabolite of hydrocortisone and analogs of cortienic acid are also devoid of corticosteroid activity. Specifically, LE is an ester derivative of one of these analogs, cortienic acid etabonate. In particular, LE possesses a metabolically labile 17 beta-chloromethyl ester function which was designed in order to be hydrolyzed to an inactive carboxylic acid moiety. This inactive metabolite is more hydrophilic and is thus readily eliminated from the body. LE also exhibits good ocular permeation properties and good skin permeation properties.
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Absorption
Loteprednol etabonate (LE) demonstrates good ocular permeation properties as it is lipid soluble, allowing the agent to penetrate into cells with relative ease. Results from the ocular administration of loteprednol in normal, healthy volunteers have shown that there are low or undetectable concentrations of either unchanged material or its metabolite. Following twice-daily unilateral topical ocular dosing of LE for 14 days in healthy subjects, the plasma concentrations of loteprednol etabonate were below the limit of quantitation (1 ng/mL) at all time points. These finds suggest that limited, if any, systemic absorption of LE occurs.
Route of Elimination
Following systemic administration to rats, loteprednol etabonate is eliminated primarily via the biliary/faecal route, with most of the dose eliminated in the form of the metabolite, PJ-90.
Volume of Distribution
The only data available regarding the volume of distribution of loteprednol etabonate (LE) is the volume of distribution the agent demonstrated when administered to dogs - a value of 3.7 L/kg. It has been shown, however, that the topical ocular administration of LE distributes preferentially into the cellular components of blood.
Clearance
Loteprednol etabonate was slowly hydrolyzed in liver at clearance rates of 0.21 +/- 0.04 and 2.41 +/- 0.13 ml/h/kg in the liver and plasma, respectively.
Loteprednol etabonate (LE) is readily and extensively metabolized to two inactive metabolites, PJ-90 (1-cortienic acid) and PJ-91 (1-cortienic acid etabonate). Metabolism occurs locally in ocular tissues, and to the extent that loteprednol etabonate reaches the systemic circulation, likely the liver and other tissues into which it distributes. In particular, studies have demonstrated that LE (chloromethyl 17alpha-ethoxycarbonyloxy-11beta-hydroxy-3-oxoandrosta-1,4-diene) is rapidly hydrolyzed at the location of its 17beta-chloromethyl ester function by paraoxonase 1 in human plasma at the site of administration at the level of the affected eye tissue to the 17beta-carboxylate PJ-91 metabolite and PJ-90 metabolite. Both metabolites are considered inactive.
The terminal half-life of loteprednol etabonate as determined when administered intravenously at a dose of 5 mg/kg in the dog animal model is 2.8 hours.
Corticosteroids like loteprednol etabonate inhibit the inflammatory response to a variety of inciting agents and likely delay or slow healing. They inhibit the edema, fibrin deposition, capillary dilation, leukocyte migration, capillary proliferation, fibroblast proliferation, deposition of collagen, and scar formation that are commonly associated with inflammation. While glucocorticoids are known to bind to and activate the glucocorticoid receptor, the molecular mechanisms involved in glucocorticoid/glucocorticoid receptor-dependent modulation of inflammation are not clearly established. Moreover, corticosteroids are thought to inhibit prostaglandin production through several independent mechanisms. In particular, corticosteroids are thought to act by the induction of phospholipase A2 inhibitory proteins, collectively called lipocortins. It is postulated that these proteins control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes by inhibiting the release of their common precursor arachidonic acid. Arachidonic acid is released from membrane phospholipids by phospholipase A2. The use of LE subsequently treats post-operative inflammation and pain following ocular surgery by managing the prostaglandin release, recruitment and travel of neutrophils and macrophages, and production of other inflammatory mediators that are intrinsically associated with the physical trauma of surgery.

API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Dosage Form : Cream / Lotion / Ointment
Grade : Topical, Parenteral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Cream / Lotion / Ointment
Grade : Topical
Application : Topical
Excipient Details : Boric acid is used as an antimicrobial preservative in topical formulations such as creams and ointments.
Pharmacopoeia Ref : EP
Technical Specs : 99.9 % Boric Acid (H3BO3)
Ingredient(s) : Boric Acid Excipient
Dosage Form : Ophthalmic Solution
Grade : Topical, Parenteral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Capsule
Grade : Oral (Pharma Grade)
Application : Fillers, Diluents & Binders
Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.
Dosage Form : Tablet
Grade : Oral (Pharma Grade)
Dosage Form : Tablet
Grade : Oral (Pharma Grade)
Dosage Form : Tablet
Grade : Oral (Pharma Grade)
Dosage Form : Tablet
Grade : Oral (Pharma Grade)
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Ophthalmic Solution
Grade : Oral, Ophthalmic, Injectable, Topical
Application : Solubilizers
Excipient Details : Tyloxapol is used as a solubilizing, emulsifying and stabilizing agent in nebulizers, eye drops, injectables, oral syrups and topical dosage forms.
Pharmacopoeia Ref : USP-NF, DMF, EXCiPAT, KOSHER, ...
Technical Specs : NA
Ingredient(s) : Tyloxapol
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Injectable / Parenteral
Grade : Parenteral, Oral, Topical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Thickeners and Stabilizers
Excipient Details : Used as a chelating agent in cell culture media, downstream and as a chelator stabilizer in Biopharmaceutical formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Disodium Edetate Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Application : Parenteral
Excipient Details : Used as an osmolarity agent in culture media, tonicity adjuster in ophthalmics and parenterals solutions.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised packaging (from grs to kilograms)
Ingredient(s) : Sodium Chloride Excipient
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Ophthalmic Solution
Grade : Ophthalmic and Nasal
Brand Name : Benzalkonium Chloride
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Benzalkonium Chloride Excipient
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Oral, Parenteral
Brand Name : Benzalkonium Chloride 17%...
Application : Solubilizers
Excipient Details : A&C’s Benzalkonium Chloride 17% is a preservative which meets the NF monograph.
Pharmacopoeia Ref : USP NF
Technical Specs : 17% USP NF
Ingredient(s) : Benzalkonium Chloride Excipient
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Oral, Parenteral
Brand Name : Benzalkonium Chloride 50%...
Application : Solubilizers
Excipient Details : A&C’s Benzalkonium Chloride 50% is a preservative which meets the NF monograph. It acts as a quarternary ammonium salt.
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Glycerol Multi-Compendial
Application : Parenteral
Excipient Details : A & C's Glycerol multi-compendial is an excipient that meets USP-NF, EP and BP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Not Available
Ingredient(s) : Glycerol Excipient
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Application : Parenteral
Excipient Details : A & C's Glycerol is an excipient which meets the USP monograph.
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Hydrochloric Acid NF
Application : Parenteral
Excipient Details : A&C's Hydrochloric Acid NF is used as a low pH neutralizing agent for pharmaceutical applications.
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : NaCl Multi-compendial Low...
Application : Parenteral
Excipient Details : A & C's Sodium Chloride multi-compendial low endotoxin is an excipient meeting USP-NF, EP, BP and JP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Low Endotoxin
Ingredient(s) : Sodium Chloride Excipient
Excipients Web Link
Dosage Form : Cream / Lotion / Ointment
Grade : Topical and Oral
Application : Topical
Excipients Web Link
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Sodium Chloride USP
Application : Parenteral
Excipient Details : A & C's Sodium Chloride is an excipient meeting the USP monograph.
Excipients Web Link
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Granule / Pellet
Grade : Not Available
Application : Granulation
Excipient Details : Tablets, Granules, Pills, Disintegrants and fillers.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Ophthalmic Solution
Grade : Conjunctival
Application : Solubilizers
Excipient Details : Tyloxapol excipient is used as an solubilizing agent in the ophthalmic products.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Ophthalmic Solution
Grade : Ophthalmic and Nasal
Brand Name : Benzalkonium Chloride
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Benzalkonium Chloride Excipient
Excipients Web Link
Dosage Form : Cream / Lotion / Ointment
Grade : Topical and Oral
Application : Topical
Excipients Web Link
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : F-Melt Type C is a pharmaceutical excipient used in oral dosage forms like orally disintegrating tablets, sachets, dispersible tablets, chewable tablets and sublingual tablets.
Pharmacopoeia Ref : Conforms to Japanese Pharmaceu...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Orodispersible Tablet
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : F-Melt Type M is used in various dosage forms like orally disintegrating tablets (ODTs), sachets, dispersible tablets, chewable tablets and sublingual formulations.
Pharmacopoeia Ref : Conforms to Japanese Pharmaceu...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Capsule
Grade : Oral
Application : Fillers, Diluents & Binders
Pharmacopoeia Ref : USP-NF, EP, BP, IP, JP, FCC
Technical Specs : PVP K-K-30/ K-17/ K19/ K25/ K90
Ingredient(s) : Povidone
Dosage Form : Capsule
Grade : Oral
Application : Solubilizers
Excipient Details : Super disintegrate, solublity enhancer, Suspension stabilizer, Complexing agent, Low peroxide content, Long term stability
Pharmacopoeia Ref : Not Available
Technical Specs : Crospovidone (Type-A/B)- USP-NF / Ph. Eur. / BP / IP
Ingredient(s) : Crospovidone
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Orodispersible Tablet
Grade : Not Available
Application : Chewable & Orodispersible Aids
Excipient Details : Orally Disintegrating Tablets
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Topical, Oral, Nasal & Ophthalmics
Brand Name : Noveon Polycarbophil
Application : Controlled & Modified Release
Pharmacopoeia Ref : United States Pharmacopeia/Nat...
Technical Specs : Viscosity, cP (0.2 wt% at pH 7.5) - 2,000 - 12,000
Ingredient(s) : Polycarbophil
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® Cr.PVD CL-110
Application : Disintegrants & Superdisintegrants
Excipient Details : It facilitates to facilitate the dissolution of poorly API due to porous surface morphology.
Pharmacopoeia Ref : Not Available
Technical Specs : Also Available as Microlex® Cr.PVD CL-25, Microlex® Cr.PVD UCL-25, Microlex® Cr.PVD UCL-110
Ingredient(s) : Crospovidone
Dosage Form : Tablet
Grade : Oral
Brand Name : Microlex® PVD K30
Application : Solubilizers
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Also Available as Microlex® PVD K90.
Ingredient(s) : Povidone
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Application : Granulation
Excipient Details : Crospovidone is used as a granulating agent in pharmaceutical formulations such as tablets, granules, and pellets.
Dosage Form : Tablet
Grade : Oral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Tablet
Grade : Oral
Dosage Form : Suspension
Grade : Oral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Softgels
Grade : Oral, Topical, Parenteral
Dosage Form : Tablet
Grade : Oral
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Capsule
Grade : Oral
Application : Disintegrants & Superdisintegrants
Excipient Details : Crospovidone is used as a disintegrant in solid oral dosage forms such as tablets and capsules.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : Solution
Grade : Oral, Topical
Application : Solubilizers
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Dosage Form : Suspension, Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants, Thickeners and Stabilizers
Application : Disintegrants & Superdisintegrants
Excipient Details : Crospovidone is used as a disintegrant in solid oral dosage forms such as tablets and capsules.
Application : Granulation
Excipient Details : Crospovidone is used as a granulating agent in pharmaceutical formulations such as tablets, granules, and pellets.
Dosage Form : Granule / Pellet, Tablet
Grade : Not Available
Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Granulation
Application : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Granulation
Excipient Details : Tablets, Granules, Pills, Disintegrants and fillers.
Dosage Form : Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders
Dosage Form : Cream / Lotion / Ointment, Ophthalmic Solution
Grade : Topical, Parenteral
Category : Solubilizers, Topical
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral, Ophthalmic Solution, Syrup
Grade : Oral, Ophthalmic, Injectable...
Category : Solubilizers, Thickeners and Stabilizers
Application : Solubilizers, Thickeners and Stabilizers
Excipient Details : Tyloxapol is used as a solubilizing, emulsifying and stabilizing agent in nebulizers, eye drops, injectables, oral syrups and topical dosage forms.
Pharmacopoeia Ref : USP-NF, DMF, EXCiPAT, KOSHER, ...
Technical Specs : NA
Ingredient(s) : Tyloxapol
Application : Solubilizers
Excipient Details : Tyloxapol excipient is used as an solubilizing agent in the ophthalmic products.
Brand Name : Benzalkonium Chloride 17% USP NF
Application : Solubilizers
Excipient Details : A&C’s Benzalkonium Chloride 17% is a preservative which meets the NF monograph.
Pharmacopoeia Ref : USP NF
Technical Specs : 17% USP NF
Ingredient(s) : Benzalkonium Chloride Excipient
Excipients Web Link
Dosage Form : Cream / Lotion / Ointment, Gel, Solution
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers, Topical
Application : Emulsifying Agents, Solubilizers, Topical
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Brand Name : Benzalkonium Chloride 50% NF
Application : Solubilizers
Excipient Details : A&C’s Benzalkonium Chloride 50% is a preservative which meets the NF monograph. It acts as a quarternary ammonium salt.
Excipients Web Link
Brand Name : Microlex® PVD K30
Application : Solubilizers
Pharmacopoeia Ref : Monograph- USP/NF, JP/JPE
Technical Specs : Also Available as Microlex® PVD K90.
Ingredient(s) : Povidone
Dosage Form : Capsule, Emulsion, Softgel Capsule, Solution, Tablet, Topical Film
Grade : Not Available
Category : Film Formers & Plasticizers, Solubilizers, Topical
Application : Film Formers & Plasticizers, Solubilizers, Topical
Excipient Details : Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Propylene Glycol
Brand Name : Microlex® Cr.PVD CL-110
Application : Disintegrants & Superdisintegrants, Solubilizers
Excipient Details : It facilitates to facilitate the dissolution of poorly API due to porous surface morphology.
Pharmacopoeia Ref : Not Available
Technical Specs : Also Available as Microlex® Cr.PVD CL-25, Microlex® Cr.PVD UCL-...
Ingredient(s) : Crospovidone
Dosage Form : Capsule, Orodispersible Tablet, Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants, Solubilizers, Thickeners and Stabilizers
Application : Disintegrants & Superdisintegrants, Solubilizers, Thickeners and Stabilizers
Excipient Details : Super disintegrate, solublity enhancer, Suspension stabilizer, Complexing agent, Low peroxide content, Long term stability
Pharmacopoeia Ref : Not Available
Technical Specs : Crospovidone (Type-A/B)- USP-NF / Ph. Eur. / BP / IP
Ingredient(s) : Crospovidone
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral
Grade : Topical, Parenteral
Category : Parenteral, Topical
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgels
Grade : Parenteral, Oral, Topical
Category : Film Formers & Plasticizers, Parenteral, Thickeners and Stabilizers, Topical
Application : Parenteral
Excipient Details : Used as an osmolarity agent in culture media, tonicity adjuster in ophthalmics and parenterals solutions.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Sodium Chloride Excipient
Dosage Form : Injectable / Parenteral
Grade : Biopharma Grade
Category : Parenteral, Thickeners and Stabilizers
Application : Parenteral, Thickeners and Stabilizers
Excipient Details : Used as a chelating agent in cell culture media, downstream and as a chelator stabilizer in Biopharmaceutical formulations.
Pharmacopoeia Ref : On Request
Technical Specs : Low bacteria endotoxins, low bioburden (TAMC/TYMC). Customised pa...
Ingredient(s) : Disodium Edetate Excipient
Dosage Form : Cream / Lotion / Ointment, Emulsion, Injectable / Parenteral, Softgels, Tablet
Grade : Oral, Topical, Parenteral
Category : Film Formers & Plasticizers, Parenteral, Topical
Dosage Form : Capsule, Cream / Lotion / Ointment
Grade : Topical and Oral
Category : Film Formers & Plasticizers, Topical
Application : Film Formers & Plasticizers, Topical
Excipients Web Link
Dosage Form : Nasal Solution, Ophthalmic Solution
Grade : Ophthalmic and Nasal
Category : Parenteral
Brand Name : Benzalkonium Chloride
Application : Parenteral
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Benzalkonium Chloride Excipient
Excipients Web Link
Brand Name : Hydrochloric Acid NF
Application : Parenteral
Excipient Details : A&C's Hydrochloric Acid NF is used as a low pH neutralizing agent for pharmaceutical applications.
Excipients Web Link
Brand Name : Sodium Chloride USP
Application : Parenteral
Excipient Details : A & C's Sodium Chloride is an excipient meeting the USP monograph.
Excipients Web Link
Brand Name : Glycerol Multi-Compendial
Application : Parenteral
Excipient Details : A & C's Glycerol multi-compendial is an excipient that meets USP-NF, EP and BP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Not Available
Ingredient(s) : Glycerol Excipient
Excipients Web Link
Application : Fillers, Diluents & Binders
Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.
Application : Disintegrants & Superdisintegrants
Excipient Details : Crospovidone is used as a disintegrant in solid oral dosage forms such as tablets and capsules.
Application : Granulation
Excipient Details : Crospovidone is used as a granulating agent in pharmaceutical formulations such as tablets, granules, and pellets.
Dosage Form : Granule / Pellet, Tablet
Grade : Not Available
Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Granulation
Application : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Granulation
Excipient Details : Tablets, Granules, Pills, Disintegrants and fillers.
Dosage Form : Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders
Dosage Form : Orodispersible Tablet, Tablet
Grade : Oral
Category : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Application : Disintegrants & Superdisintegrants, Fillers, Diluents & Binders, Taste Masking
Excipient Details : F-Melt Type C is a pharmaceutical excipient used in oral dosage forms like orally disintegrating tablets, sachets, dispersible tablets, chewable tablets and sublingual tablets.
Pharmacopoeia Ref : Conforms to Japanese Pharmaceu...
Technical Specs : Not Available
Ingredient(s) : Crospovidone
Dosage Form : Cream / Lotion / Ointment, Injectable / Parenteral
Grade : Topical, Parenteral
Category : Parenteral, Topical
Dosage Form : Cream / Lotion / Ointment, Ophthalmic Solution
Grade : Topical, Parenteral
Category : Solubilizers, Topical
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgels
Grade : Parenteral, Oral, Topical
Category : Film Formers & Plasticizers, Parenteral, Thickeners and Stabilizers, Topical
Application : Topical
Excipient Details : Boric acid is used as an antimicrobial preservative in topical formulations such as creams and ointments.
Pharmacopoeia Ref : EP
Technical Specs : 99.9 % Boric Acid (H3BO3)
Ingredient(s) : Boric Acid Excipient
Dosage Form : Cream / Lotion / Ointment, Emulsion, Injectable / Parenteral, Softgels, Tablet
Grade : Oral, Topical, Parenteral
Category : Film Formers & Plasticizers, Parenteral, Topical
Dosage Form : Cream / Lotion / Ointment, Gel, Solution
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers, Topical
Application : Emulsifying Agents, Solubilizers, Topical
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Dosage Form : Capsule, Cream / Lotion / Ointment
Grade : Topical and Oral
Category : Film Formers & Plasticizers, Topical
Application : Film Formers & Plasticizers, Topical
Excipients Web Link
Dosage Form : Capsule, Emulsion, Softgel Capsule, Solution, Tablet, Topical Film
Grade : Not Available
Category : Film Formers & Plasticizers, Solubilizers, Topical
Application : Film Formers & Plasticizers, Solubilizers, Topical
Excipient Details : Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Propylene Glycol
Global Sales Information
Company : Bausch & Lomb I
Loteprednol Etabonate
Drug Cost (USD) : 10,907,860
Year : 2023
Prescribers : 13226
Prescriptions : 26614

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Kala/Alcon Labo
Loteprednol Etabonate
Drug Cost (USD) : 10,878,526
Year : 2023
Prescribers : 12546
Prescriptions : 19453

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Kala/Alcon Labo
Loteprednol Etabonate
Drug Cost (USD) : 2,723,645
Year : 2023
Prescribers : 3984
Prescriptions : 7838

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Bausch & Lomb I
Loteprednol Etabonate
Drug Cost (USD) : 10,831,409
Year : 2023
Prescribers : 15993
Prescriptions : 28480

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Bausch & Lomb I
Loteprednol Etabonate
Drug Cost (USD) : 20,534,043
Year : 2023
Prescribers : 43117
Prescriptions : 75703

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Akorn Inc.
Loteprednol Etabonate
Drug Cost (USD) : 3,232,366
Year : 2023
Prescribers : 11715
Prescriptions : 16379

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Bausch & Lomb I
Loteprednol Etabonate
Drug Cost (USD) : 4,330,332
Year : 2023
Prescribers : 13982
Prescriptions : 27019

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Oceanside Pharm
Loteprednol Etabonate
Drug Cost (USD) : 21,463,994
Year : 2023
Prescribers : 62459
Prescriptions : 104763

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Sun Pharmaceuti
Loteprednol Etabonate
Drug Cost (USD) : 4,164,083
Year : 2023
Prescribers : 15821
Prescriptions : 21623

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Bausch & Lomb I
Tobramycin/Lotepred Etab
Drug Cost (USD) : 3,777,050
Year : 2023
Prescribers : 6592
Prescriptions : 9258

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
89
PharmaCompass offers a list of Loteprednol Etabonate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Loteprednol Etabonate manufacturer or Loteprednol Etabonate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Loteprednol Etabonate manufacturer or Loteprednol Etabonate supplier.
PharmaCompass also assists you with knowing the Loteprednol Etabonate API Price utilized in the formulation of products. Loteprednol Etabonate API Price is not always fixed or binding as the Loteprednol Etabonate Price is obtained through a variety of data sources. The Loteprednol Etabonate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Alrex;Lotemax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alrex;Lotemax, including repackagers and relabelers. The FDA regulates Alrex;Lotemax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alrex;Lotemax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Alrex;Lotemax manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Alrex;Lotemax supplier is an individual or a company that provides Alrex;Lotemax active pharmaceutical ingredient (API) or Alrex;Lotemax finished formulations upon request. The Alrex;Lotemax suppliers may include Alrex;Lotemax API manufacturers, exporters, distributors and traders.
click here to find a list of Alrex;Lotemax suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Alrex;Lotemax DMF (Drug Master File) is a document detailing the whole manufacturing process of Alrex;Lotemax active pharmaceutical ingredient (API) in detail. Different forms of Alrex;Lotemax DMFs exist exist since differing nations have different regulations, such as Alrex;Lotemax USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Alrex;Lotemax DMF submitted to regulatory agencies in the US is known as a USDMF. Alrex;Lotemax USDMF includes data on Alrex;Lotemax's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Alrex;Lotemax USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Alrex;Lotemax suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Alrex;Lotemax Drug Master File in Korea (Alrex;Lotemax KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Alrex;Lotemax. The MFDS reviews the Alrex;Lotemax KDMF as part of the drug registration process and uses the information provided in the Alrex;Lotemax KDMF to evaluate the safety and efficacy of the drug.
After submitting a Alrex;Lotemax KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Alrex;Lotemax API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Alrex;Lotemax suppliers with KDMF on PharmaCompass.
A Alrex;Lotemax written confirmation (Alrex;Lotemax WC) is an official document issued by a regulatory agency to a Alrex;Lotemax manufacturer, verifying that the manufacturing facility of a Alrex;Lotemax active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Alrex;Lotemax APIs or Alrex;Lotemax finished pharmaceutical products to another nation, regulatory agencies frequently require a Alrex;Lotemax WC (written confirmation) as part of the regulatory process.
click here to find a list of Alrex;Lotemax suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Alrex;Lotemax as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Alrex;Lotemax API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Alrex;Lotemax as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Alrex;Lotemax and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Alrex;Lotemax NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Alrex;Lotemax suppliers with NDC on PharmaCompass.
Alrex;Lotemax Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Alrex;Lotemax GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alrex;Lotemax GMP manufacturer or Alrex;Lotemax GMP API supplier for your needs.
A Alrex;Lotemax CoA (Certificate of Analysis) is a formal document that attests to Alrex;Lotemax's compliance with Alrex;Lotemax specifications and serves as a tool for batch-level quality control.
Alrex;Lotemax CoA mostly includes findings from lab analyses of a specific batch. For each Alrex;Lotemax CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Alrex;Lotemax may be tested according to a variety of international standards, such as European Pharmacopoeia (Alrex;Lotemax EP), Alrex;Lotemax JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alrex;Lotemax USP).